Global Expansion KUR Research is expanding internationally with Chennai, India operations and a global emphasis under KUR International, presenting a sales opportunity to provide cross-border CRO services, regulatory support, and international patient access for multi-region trials.

Clinical Footprint With a decade of experience and hundreds of trials including over 100 medical device and diagnostic studies, KUR demonstrates a strong track record and diverse trial experience that can be leveraged to win new studies requiring high-quality data and rapid enrollment.

Commercial Leadership Recent executive appointment of a President and Chief Commercial Officer signals a sharpened go-to-market strategy and potential for expanded business development efforts, ideal for partnerships, sponsors, and site-network collaborations.

Data and Tech Adoption of modern tech stack (Looker, Power BI, Google Cloud, DocuSign, Azure, Teams) indicates robust data management, virtual collaboration, and streamlined trial processes that can be highlighted to sponsors seeking digital-first, efficient study execution.

Financial Cue Annual revenue in the $1M–$10M range and a network of 11–50 employees suggest a mid-market partner opportunity for sponsors targeting cost-effective sites with reliable enrollment and strong retention metrics, especially in device and diagnostic trials.